NCT05407428View on ClinicalTrials.gov

A Prospective Study to Evaluate the Correlation Between Oculometric Measurements and Clinical Endpoints in ALS Patients

CompletedOBSERVATIONAL
Enrollment

45

Participants

Timeline

Start Date

May 31, 2022

Primary Completion Date

October 28, 2024

Study Completion Date

October 28, 2024

Conditions
Amyotrophic Lateral Sclerosis
Interventions
OTHER

NeuraLight software-based platform

NeuraLight is an investigational software-based platform that is used for assessment and evaluation of neurological conditions including ALS patients

Trial Locations (1)

6423906

Sourasky medical center, Tel Aviv

Sponsors

Lead Sponsor

NeuraLight
All Listed Sponsors
lead

NeuraLight

INDUSTRY

NCT05407428 - A Prospective Study to Evaluate the Correlation Between Oculometric Measurements and Clinical Endpoints in ALS Patients | Biotech Hunter | Biotech Hunter